BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint

A simple technique for quantitation of low levels of DNA damage in individual cells

Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90265-0 · Cited by 10,828

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237

Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome

Daley, G. Q., Etten, R. A. V., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 2,141

Cell cycle checkpoint signaling through the ATM and ATR kinases

Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966

Chk1 is an essential kinase that is regulated by Atr and required for the G 2 /M DNA damage checkpoint

Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625

ATR disruption leads to chromosomal fragmentation and early embryonic lethality

Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

Gong, J., Costanzo, A., Yang, H., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 923

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity

Konopka, J. B., Watanabe, S. M., & Witte, O. N. (1984) · Cell · doi:10.1016/0092-8674(84)90438-0 · Cited by 872

Radiosensitivity in ataxia-telangiectasia: a new explanation.

Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 795

Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow

Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R. T., Aster, J. C., Scott, M. L., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3780 · Cited by 761

Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A

Sørensen, C. S., Syljuåsen, R. G., Falck, J., Schroeder, T., Rönnstrand, L., Khanna, K. K., Zhou, B.-B., Bártek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00048-5 · Cited by 588

Interaction of c-Abl and p73α and their collaboration to induce apoptosis

Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 544

Overexpression of a kinase‐inactive ATR protein causes sensitivity to DNA‐damaging agents and defects in cell cycle checkpoints

Cliby, W. A., Roberts, C. J., Cimprich, K. A., Stringer, C. M., Lamb, J. R., Schreiber, S. L., & Friend, S. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.159 · Cited by 542

Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation

Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A. J., Kastan, M. B., et al. (1997) · Nature · doi:10.1038/387516a0 · Cited by 538

Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance

Brown, E. J., & Baltimore, D. (2003) · Genes & Development · doi:10.1101/gad.1067403 · Cited by 511

Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

Bedi, A., Zehnbauer, B., Barber, J. P., Sharkis, S. J., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 506

Interaction between ATM protein and c-Abl in response to DNA damage

Shafman, T. D., Khanna, K. K., Kedar, P. S., Spring, K. J., Kozlov, S., Yen, T. J., Hobson, K., Gatei, M. H., Zhang, N., Watters, D. J., et al. (1997) · Nature · doi:10.1038/387520a0 · Cited by 478

Maintenance of Genome Stability in Saccharomyces cerevisiae

Kolodner, R. D., Putnam, C. D., & Myung, K. (2002) · Science · doi:10.1126/science.1075277 · Cited by 470

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

Etten, R. A. V., Jackson, P. K., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90102-5 · Cited by 425

An ATR- and Cdc7-Dependent DNA Damage Checkpoint that Inhibits Initiation of DNA Replication

Costanzo, V., Shechter, D., Lupardus, P. J., Cimprich, K. A., Gottesman, M. E., & Gautier, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00799-2 · Cited by 355

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase

Vigneri, P. G., & Wang, J. Y. J. (2001) · Nature Medicine · doi:10.1038/84683 · Cited by 333

BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance

Słupianek, A., Schmütte, C., Tombline, G., Nieborowska-Skorska, M., Hoser, G., Nowicki, M. O., Pierce, A. J., Fishel, R. A., & Skórski, T. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00357-4 · Cited by 313

Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase

Taagepera, S., McDonald, D., Loeb, J. E., Whitaker, L. L., McElroy, A. K., Wang, J. Y. J., & Hope, T. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7457 · Cited by 311

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

Ahuja, H., Bar‐Eli, M., Advani, S. H., Benchimol, S., & Cline, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6783 · Cited by 284

Regulation of cell death by the Abl tyrosine kinase

Wang, J. Y. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203878 · Cited by 279

Defective S Phase Chromatin Assembly Causes DNA Damage, Activation of the S Phase Checkpoint, and S Phase Arrest

Ye, X., Franco, A. A., Santos, H., Nelson, D. M., Kaufman, P. D., & Adams, P. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00037-6 · Cited by 271

An ATR- and Chk1-Dependent S Checkpoint Inhibits Replicon Initiation following UVC-Induced DNA Damage

Heffernan, T. P., Simpson, D. A., Frank, A. R., Heinloth, A. N., Paules, R. S., Cordeiro-Stone, M., & Kaufmann, W. K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8552-8561.2002 · Cited by 251

Radiosensitivity in ataxia-telangiectasia

Cunliffe, P. N., Mann, J. R., Cameron, A., Roberts, K. D., & Ward, H. W. C. (1975) · British Journal of Radiology · doi:10.1259/0007-1285-48-569-374 · Cited by 189

Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

Wetzler, M., Talpaz, M., Etten, R. A. V., Hirsch‐Ginsberg, C., Beran, M., & Kurzrock, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116786 · Cited by 188

The Survival Function of the Bcr-Abl Oncogene Is Mediated by Bad-Dependent and -Independent Pathways: Roles for Phosphatidylinositol 3-Kinase and Raf

Neshat, M. S., Raitano, A. B., Wang, H., Reed, J. C., & Sawyers, C. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1179-1186.2000 · Cited by 185

Determination of cell fate by c-Abl activation in the response to DNA damage

Kharbanda, S. M., Yuan, Z.-M., Weichselbaum, R. W., & Kufe, D. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202571 · Cited by 166

BCR-ABL down-regulates the DNA repair protein DNA-PKcs

Deutsch, É., Dugray, A., Abdulkarim, B., Marangoni, E., Maggiorella, L., Vaganay, S., M'Kacher, R., Douc‐Rasy, S., Eschwège, F., Vainchenker, W., et al. (2001) · Blood · doi:10.1182/blood.v97.7.2084 · Cited by 166

Initiation of Deregulated Growth of Multipotent Progenitor Cells by bcr-abl in Vitro

Gishizky, M. L., & Witte, O. N. (1992) · Science · doi:10.1126/science.1375394 · Cited by 160

BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia

Salesse, S., & Verfaillie, C. M. (2002) · Oncogene · doi:10.1038/sj.onc.1206082 · Cited by 147

Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression.

Klucher, K., Lopez, D. V., & Daley, G. (1998) · Blood · doi:10.1182/blood.v91.10.3927.3927_3927_3934 · Cited by 133

Secondary Mutation Maintains the Transformed State in BaF3 Cells With Inducible BCR/ABL Expression

Klucher, K. M., Lopez, D. V., & Daley, G. Q. (1998) · Blood · doi:10.1182/blood.v91.10.3927 · Cited by 122

Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cells

Deutsch, É., Jarrousse, S., Selimoglu‐Buet, D., Dugray, A., Bonnet, M., Vozenin, M., Guilhot, F., Turhan, A. G., Feunteun, J., & Bourhis, J. (2003) · Blood · doi:10.1182/blood-2002-10-3011 · Cited by 100

The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein

Takeda, N., Shibuya, M., & Maru, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.203 · Cited by 79

DNA damage enables p73

White, E., & Prives, C. L. (1999) · Nature · doi:10.1038/21539 · Cited by 65

DOES THE BCR/ABL‐MEDIATED INCREASE IN THE EFFICACY OF DNA REPAIR PLAY A ROLE IN THE DRUG RESISTANCE OF CANCER CELLS?

Majsterek, I., Błasiak, J., Mlynarski, W. M., Hoser, G., & Skórski, T. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0865 · Cited by 33

Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia

Grießhammer, M., Heinze, B., Bangerter, M., Heimpel, H., & Fliedner, T. M. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050173 · Cited by 30

Checking on DNA damage in S phase

Bartek, J., Lukas, C., & Lukas, J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1493 · Cited by 758

Chronic myeloid leukaemia as a model of disease evolution in human cancer

Melo, J. V., & Barnes, D. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2147 · Cited by 629

The biology of CML blast crisis

Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 608

Cell Cycle Regulation of DNA Replication

Sclafani, R. A., & Holzen, T. M. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130308 · Cited by 463

High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy

Willis, S. G., Lange, T., Demehri, S., Otto, S., Crossman, L. C., Niederwieser, D. W., Stoffregen, E. P., McWeeney, S. K., Kovacs, I., Park, B. S., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1036 · Cited by 301

BCR/ABL Expression Increases the Formation of Chromosomal Translocations after DNA Damage.

Dierov, J. K., Padilla‐Nash, H. M., Ried, T., & Carroll, M. P. (2004) · Blood · doi:10.1182/blood.v104.11.713.713 · Cited by 1

The Effects of BCR/ABL on DNA Damage and Repair Are Dependent on Apoptosis Competence

Burke, B. A., & Carroll, M. P. (2008) · Blood · doi:10.1182/blood.v112.11.4216.4216

BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold

Dierov, J. K., Sanchez, P. V., Burke, B. A., Padilla‐Nash, H. M., Putt, M. E., Ried, T., & Carroll, M. P. (2008) · Leukemia · doi:10.1038/leu.2008.308 · Cited by 33

BCR–ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia

Burke, B. A., & Carroll, M. P. (2010) · Leukemia · doi:10.1038/leu.2010.67 · Cited by 92

EFFECTS OF THE BCR-ABL ONCOGENE ON DNA DAMAGE AND REPAIR

Burke, B. A., Beth, A., Brown, E. J., Johnson, F. B., Abstract, P., & Carroll, M. (2010)